Oxford Science Enterprises appoints Richard Laxer, former Chairman and CEO of GE Capital, as Non-Executive Director

OXFORD, England, April 19, 2022 /PRNewswire/ — Oxford Science Enterprises, the Science Business Builder transforming the world’s cutting edge science University of Oxford in companies that change the world, announces today the appointment of Richard Laxer to its board of directors, as an independent non-executive director.

Richard is a GE Capital veteran, serving the company for 34 years before retiring in 2018 as CEO and Chairman. Richard held several management positions at GE Capital in the United States, Asia and Europeleading global teams to develop and execute funding strategies critical to the success of a wide range of multi-billion dollar global businesses.

Since leaving GE Capital, Richard has used his experience and expertise to advise companies that are using cutting-edge and innovative technologies to disrupt the financial services industry. Richard was a senior adviser to Warburg Pincus and is currently a non-executive director of three of its portfolio companies: Vodeno Technology, Aion and Singular Bank.

“I am delighted to welcome Rich to the board of Oxford Science Enterprises,” mentioned Chris ChambersPresident of the council. “He has had a hugely successful career in the global financial services industry, where he has an outstanding track record of growing and transforming a diverse portfolio of businesses, including start-ups. His financial expertise and networks are a complementary addition to the board, and I look forward to working with him to leverage his leadership and operational experience to support our portfolio of high-potential technology and life sciences companies that are ready to make a positive change in the world.”

“I am delighted to join the board of directors of Oxford Science Enterprises”, mentioned Richard Laxer. “Pioneering science and technology from the University of Oxford has significant potential to address some of the major global impact challenges we face today. I am excited to support the company in its investments and to champion these new ventures in new disruptive ventures.”

Richard has a proven track record of navigating complex market conditions, managing enterprise risk alongside restructuring and integrating large companies to achieve financial goals. His extensive expertise in funding strategies including private equity, debt, corporate and commercial finance will be invaluable in leading Oxford Science Enterprises’ global ambition to transform world-leading science into a high-value portfolio of companies that change the world.

Richard joined GE Capital in 1984 after earning a Bachelor of Commerce, with a minor in Economics, from Skidmore College, Saratoga Springs, NYWE.

About Oxford Science Enterprises

We are Oxford Science Enterprises, the builder of science enterprises. We want to help solve the world’s toughest problems for more people, in more places, faster. We do this by transforming cutting-edge science into world-changing companies, pairing the best scientists from the world’s best university with the best minds in business. We develop our businesses with care and expertise; in a systematic and progressive way. We invest for real impact, not just financial returns. And we reinvest the profits in the next generation of original research and world-changing companies.

Our companies tackle issues that affect people in ways that change their lives: their health, the availability of food, the survival of the planet. Since 2015, we have received automatic participation in all Oxford University scientific impact – more than 100 companies founded by more than 200 of from Oxford leading academics. We have played a leading role in the creation and construction of more 70 of these, add +55,000 square feet of lab and boot space to support them. Today our companies are worth more £2 billion and have created +2,000 jobs.

Follow us: oxfordscienceenterprises.com | Twitter | LinkedIn | Quarterly News

contacts:

Oxford Scientific Enterprises

Lisa Bedwell[email protected]

For media inquiries:

swallow mark, Sandi Greenwood, Eleanor Perkin – MEDISTRVA Consulting

[email protected]

SOURCEOxford Science Enterprises

.

Leave a Comment